GOOD NEWS from Alzheimer's Disease Research

Positive things that are happening in the fight against Alzheimer's

A reader recently noted to us that all he saw on our site was defensive strategy, how to stay ahead of the demons, etc.  He pointed out that, while defense is important, even crucial, it's not enough.  You cannot win a game or a battle by defense alone.  What about offense?  What's happening on the offensive side of this game?

We thought about that for a bit, and decided that he was right on!  Moreover defense is prevention, negative.  Offense is attacking and scoring, positive.  It's time we looked at the good news also.  So we started up this "Good News Corner", which is and will be about positive things happening in the struggle to live our lives free of Alzheimer's and other dementias.

Click on the headers to the articles or news items below that interest you.

• Experimental drug AF267B
  For the first time, an experimental drug has been successful in reducing two types of brain lesions present en Alzheimer's disease. The tests demonstrated that the compound AF267B slowed and reversed the formations of both beta-amyloidal plaques and the presence of fiber tangles of the tau protein in the brains oflaboratory mice. These types of brain lesions are common in people with Alzheimer's disease.
  
  
• Treatments Being Developed
  The race is on for the next generation of Alzheimer's treatments and drugs. Here are the three front-runners, two based on Selective Amyloid beta-42 Lowering Agents (SALAs) and one based on humanized monoclonal antibodies. Whichever one wins the race, we all win!